<--- Back to Details
First PageDocument Content
Hepatocellular carcinoma / Metastatic liver disease / Adjuvant therapy / Liver cancer / Hepatectomy / Colorectal cancer / Oxaliplatin / Melanoma / Bevacizumab / Medicine / Hepatology / Metastasectomy
Hepatocellular carcinoma
Metastatic liver disease
Adjuvant therapy
Liver cancer
Hepatectomy
Colorectal cancer
Oxaliplatin
Melanoma
Bevacizumab
Medicine
Hepatology
Metastasectomy

Schimanski et al. BMC Cancer 2012, 12:144 http://www.biomedcentral.com[removed]

Add to Reading List

Source URL: www.biomedcentral.com

Download Document from Source Website

File Size: 1,15 MB

Share Document on Facebook

Similar Documents

ABSTRACT Hepatocellular carcinoma (HCC), is increasingly common among those aging with HIV (HIV+). Compared with uninfected persons, HIV+ patients have a 4-fold increased risk of HCC. As HIV+ patients continue to age, HC

DocID: 1v5Er - View Document

Current Challenges in Systemic Therapy for Hepatocellular Carcinoma APASL STC, 23, Nov., 2013, Cebu Ann-Lii Cheng M.D., Ph.D. Professor and Chairman, Department of Oncology,

DocID: 1uS8V - View Document

HEPCAR_brochure_27june2017_Layout:00 Pagina 1 Mech anisms underl ying hepatocellular carcinoma pathogenesis and impact of co-morbidities THE PROBLEM

DocID: 1uBCQ - View Document

Ongoing Clinical Trials in Hepatocellular Carcinoma Pierce K.H Chow MD PhD

DocID: 1tZOI - View Document

Challenges in diagnosis of hepatocellular carcinoma Do Young Kim Department of Internal Medicine, Yonsei University College of Medicine

DocID: 1tP8u - View Document